Kiniksa Pharmaceuticals
KNSA
KNSA
200 hedge funds and large institutions have $1.59B invested in Kiniksa Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 58 increasing their positions, 69 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 188 → 200 (+12)
0.1% less ownership
Funds ownership: 94.07% → 93.97% (-0.1%)
16% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 69
Holders
200
Holding in Top 10
5
Calls
$24.1M
Puts
$3.82M
Top Buyers
| 1 | +$15.4M | |
| 2 | +$15.3M | |
| 3 | +$13.6M | |
| 4 |
D.E. Shaw & Co
New York
|
+$13.3M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$12.9M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$12.9M | |
| 3 | -$10.9M | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$10.7M |
| 5 |
BlackRock
New York
|
-$9.52M |
